Bold Plans for Cancer Care at Yale Eric Winer, MD, began his tenure at Yale in February 2022 with a vision to expand the cancer program and national prominence of Yale Cancer Center and Smilow Cancer Hospital. He is already recruiting more physicians and researchers and focusing on healthcare inequities in Connecticut. Throughout his planning, Dr. Winer emphasizes that everything he does is influenced by his experiences taking care of patients.

An internationally renowned expert in breast cancer.

“Among a field of outstanding candidates, Eric stood out for his leadership and for his commitment to ensuring that Yale Cancer Center and Smilow Cancer Hospital have a lasting and transformative impact on the prevention, diagnosis, and treatment of cancer,” said Dr. Nancy J. Brown, the Jean and David W. Wallace Dean of Medicine at Yale School of Medicine.

In his new role, Winer will work to promote paradigm-changing discovery and to build an unparalleled clinical program that offers seamless, multidisciplinary care and clinical trials to all patients, eliminating disparities in access, care, and outcomes.

“Dr. Winer is a nationally recognized leader in breast cancer care and research, a much sought-after mentor for younger clinicians, and an advocate for his patients,” said Marna P. Borgstrom, chief executive officer, Yale New Haven Health System. “We are delighted to welcome him to Smilow Cancer Hospital where he’ll lead a team that shares his passion and commitment to providing exceptional care to cancer patients.”

Winer has published over 350 original manuscripts and has served as the principal investigator of a National Institutes of Health-funded SPORE in Breast Cancer for the last 10 years. He is president-elect of the American Society of Clinical Oncology (ASCO) and a member of the Scientific Advisory Board of the Breast Cancer Research Foundation. For over a decade, he served as chief scientific advisor and chair of the Scientific Advisory Board for Susan G. Komen for the Cure. He currently co-leads the National Cancer Institute Breast Cancer Steering Committee.

Winer is an alumnus of both Yale College and Yale School of Medicine. After receiving his medical degree in 1983, he completed training in internal medicine, serving as chief resident at Yale New Haven Hospital. He completed a fellowship in hematology/oncology at Duke University School of Medicine and served on the Duke faculty from 1989 to 1997, before joining Dana-Farber and Brigham and Women’s Hospital.

“I am thrilled to be returning to Yale,” said Winer. “As a community, I believe we can become a premier cancer center in the next five years. I look forward to building upon the strong clinical and research programs already in place and to enhance collaborations between laboratory and clinical investigators.”

Additional Readings:
​Dr. Eric Winer's Unusual Journey Home
Yale Cancer Center's New Director, Eric P. Winer, MD

Alfred Gilman Professor of Medicine and Pharmacology Director, Yale Cancer Center Physician-in-Chief Smilow Cancer Hospital.

Dr. Eric Winer is an internationally renowned expert in breast cancer and President-Elect of the American Society of Clinical Oncology(ASCO)

This link leads to an Apple Podcast Preview interview with Dr. Winer which is quite informative.

Born with hemophilia in a time before effective therapies existed and having experienced treatment complications including hepatitis C and HIV, Dr. Eric Winer spent much of his childhood and young adulthood in and out of the hospital. Today, he is the Director of Yale Cancer Center and President of the American Society of Clinical Oncology (ASCO), the largest organization of clinicians caring for cancer patients. An internationally renowned expert in breast cancer, his research has immensely impacted how breast cancer is now treated. In this episode, Dr. Winer shares his path to oncology and his insights from being a lifelong patient on stigma, compassion, and empathy.

Copyright The Doctor’s Art Podcast 2022

Dr. Eric Winer